Status:
COMPLETED
COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB)
Lead Sponsor:
Rennes University Hospital
Collaborating Sponsors:
Fonds NOMINOE
Conditions:
Coronavirus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Since the start of this epidemic, numerous clinical and fundamental studies have been conducted to best adapt the individual management of COVID-19 cases \[1-6\]. In parallel with this work, it is nec...
Detailed Description
The first cases of the new coronavirus disease 2019 (COVID-19) due to the SARS-CoV-2 virus were reported in December 2019 in Wuhan, China. Since that date, a significant circulation of the virus aroun...
Eligibility Criteria
Inclusion
- Employees of voluntary establishments of GHT Haute-Bretagne
- Employees over the age of 18
- Having signed a free, informed and written consent.
Exclusion
- Employees subject to legal protection (safeguard of justice, guardianship, curatorship)
Key Trial Info
Start Date :
May 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2020
Estimated Enrollment :
9453 Patients enrolled
Trial Details
Trial ID
NCT04416308
Start Date
May 29 2020
End Date
October 12 2020
Last Update
May 24 2023
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
CENTRE HOSPITALIER de VITRE_ Saint Jean (La Guerche)
La Guerche-de-Bretagne, La Guerche-de-Bretagne, France, 35130
2
Centre Hospitalier de Fougeres
Fougères, France, 35300
3
Centre Hospitalier Grand Fougeray
Grand-Fougeray, France, 35390
4
Centre Hospitalier de La Roche Aux Fees
Janzé, France, 35150